RAPPUOLI, RINO
 Distribuzione geografica
Continente #
EU - Europa 569
NA - Nord America 479
AS - Asia 74
AF - Africa 3
SA - Sud America 1
Totale 1.126
Nazione #
US - Stati Uniti d'America 473
IT - Italia 196
IE - Irlanda 139
GB - Regno Unito 76
CN - Cina 43
SE - Svezia 43
DE - Germania 34
UA - Ucraina 30
FR - Francia 29
VN - Vietnam 14
FI - Finlandia 13
ES - Italia 7
CA - Canada 3
IL - Israele 3
IN - India 3
TR - Turchia 3
ZA - Sudafrica 3
AM - Armenia 2
IR - Iran 2
MX - Messico 2
MY - Malesia 2
CY - Cipro 1
DK - Danimarca 1
KG - Kirghizistan 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
Totale 1.126
Città #
Dublin 136
Fairfield 76
Southend 68
Ashburn 57
Chandler 44
Siena 44
Woodbridge 35
Seattle 31
Florence 25
Jacksonville 25
Wilmington 24
Houston 20
Cambridge 19
Ann Arbor 18
Rome 18
Dong Ket 14
Princeton 14
New York 11
Nanjing 10
Shanghai 10
Washington 9
Milan 8
Helsinki 7
San Mateo 6
Beijing 5
Catania 5
Magdeburg 4
Monteriggioni 4
Málaga 4
San Diego 4
Barcelona 3
Boardman 3
Campi Bisenzio 3
Colombes 3
Istanbul 3
Kunming 3
Nanchang 3
Norwalk 3
Parma 3
Abbadia San Salvatore 2
Agliana 2
Beersheba 2
Bologna 2
Brescia 2
Cape Town 2
Castelnuovo Rangone 2
Foiano della Chiana 2
Fremont 2
Lanciano 2
Napoli 2
Nashville 2
Pistoia 2
Selangor 2
Serra 2
Taizhou 2
Tijuana 2
Toronto 2
Trieste 2
Volla 2
Yerevan 2
Aubervilliers 1
Bad Abbach 1
Bagno a Ripoli 1
Berlin 1
Bishkek 1
Bracciano 1
Caserta 1
Castel San Lorenzo 1
Changchun 1
Changsha 1
Chicago 1
Chiusi della Verna 1
Colle di Val d'Elsa 1
Copenhagen 1
Delebio 1
Delhi 1
Favaro Veneto 1
Foggia 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Hebei 1
Lappeenranta 1
Lima 1
Livorno 1
London 1
Los Angeles 1
Modena 1
Montevarchi 1
Morazzone 1
New Delhi 1
Oria 1
Osnabrück 1
Palermo 1
Pasadena 1
Poggibonsi 1
Port Elizabeth 1
Portland 1
Prescot 1
Prossedi 1
Totale 864
Nome #
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 165
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 129
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 129
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses 125
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly 121
Inhibition of Helicobacter pylori urease by omeprazole 116
Use of pseudotyped particles expressing influenza A/Viet Nam/1194/2004 haemagglutinin in immunological assays 93
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 77
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 72
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 72
Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis 39
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 12
Totale 1.150
Categoria #
all - tutte 3.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 0 20
2019/2020134 17 5 12 28 9 8 11 17 9 10 3 5
2020/2021146 9 9 2 9 2 9 21 16 16 17 15 21
2021/2022174 12 25 14 13 9 10 11 13 4 11 19 33
2022/2023265 13 15 32 29 31 53 5 29 17 9 18 14
2023/2024311 12 4 31 22 22 83 90 10 6 8 19 4
Totale 1.150